Visualizando por Autor CALLEGARO, DAGOBERTO

Ir a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
o entre con las primeras letras:  
Mostrando reg. 1 a 9 de 9
Fecha de PublicaciónTítuloAutor(s)
2022Asymptomatic MRI lesions in pediatric-onset AQP4-IgG positive NMOSDPAOLILO, RENATA BARBOSA; RIMKUS, CAROLINA DE MEDEIROS; DA PAZ, JOSÉ ALBINO, etc.
2018Brazilian Consensus for the Treatment of Multiple Sclerosis: Brazilian Academy of Neurology and Brazilian Committee on Treatment and Research in Multiple SclerosisMARQUES, VANESSA DACCACH; PASSOS, GIORDANI RODRIGUES DOS; MENDES, MARIA FERNANDA, etc.
2020Characterization of pain syndromes in patients with neuromyelitis opticaVALERIO, FERNANDA; APOSTOLOS'PEREIRA, SAMIRA L.; Douglas Kazutoshi Sato, etc.
2022Clinical and MRI measures to identify non-acute MOG-antibody disease in adultsCORTESE, ROSA; BATTAGLINI, MARCO; PRADOS, FERRAN, etc.
2020CSF levels of glutamine synthetase and GFAP to explore astrocytic damage in seronegative NMOSDKLEEREKOOPER, IRIS; HERBERT, MEGAN K; KUIPERIJ, H BEA, etc.
2021Long-term safety of azathioprine for treatment of neuromyelitis optica spectrum disordersGOMES, ANA BEATRIZ AYROZA GALVÃO RIBEIRO; PITOMBEIRA, MILENA SALES; Douglas Kazutoshi Sato, etc.
2018MOG-IgG-Associated Optic Neuritis, Encephalitis, and Myelitis: Lessons Learned From Neuromyelitis Optica Spectrum DisorderDOS PASSOS, GIORDANI RODRIGUES; OLIVEIRA, LUANA MICHELLI; DA COSTA, BRUNA KLEIN, etc.
2023Neuromyelitis optica spectrum disorders: a review with a focus on children and adolescentsPAOLILO, RENATA BARBOSA; PAZ, JOSÉ ALBINO DA; APÓSTOLOS-PEREIRA, SAMIRA LUISA, etc.
2020Treatment of MOG-IgG-associated disorder with rituximab: an international study of 121 patientsWHITTAM, DANIEL H; COBO-CALVO, ALVARO; LOPEZ-CHIRIBOGA, A SEBASTIAN, etc.